Matches in Wikidata for { <http://www.wikidata.org/entity/Q91189125> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91189125 description "article scientifique publié en 2018" @default.
- Q91189125 description "artículu científicu espublizáu en payares de 2018" @default.
- Q91189125 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91189125 description "scientific article published on 27 November 2018" @default.
- Q91189125 description "wetenschappelijk artikel" @default.
- Q91189125 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q91189125 name "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 name "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 type Item @default.
- Q91189125 label "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 label "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 prefLabel "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 prefLabel "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 P1433 Q91189125-C6598166-D09F-4792-AB7E-1F25145ADF5A @default.
- Q91189125 P1476 Q91189125-2A23BC69-8E4B-4B78-95B5-A646E6F66FE3 @default.
- Q91189125 P2093 Q91189125-1EC7B28C-D9C7-4E78-9273-310307E0A9EC @default.
- Q91189125 P2093 Q91189125-1ED82184-19EE-49A1-A57D-E109377AB15C @default.
- Q91189125 P2093 Q91189125-5C314A7D-A893-4781-9F6A-AD4A0584B03F @default.
- Q91189125 P2093 Q91189125-8BAB1CEB-5E01-48DB-A6E1-31F7F4DD8ADF @default.
- Q91189125 P2093 Q91189125-8E9FFCA6-E334-4F72-9BDD-06B628ACC31C @default.
- Q91189125 P2093 Q91189125-8F28CF8F-181E-4FD4-8291-C59B1338A09D @default.
- Q91189125 P2093 Q91189125-C7A3A465-B826-4DAC-9828-1C601455728A @default.
- Q91189125 P2093 Q91189125-CDAEF8E2-5D86-475B-90B3-A200EA73FB55 @default.
- Q91189125 P2093 Q91189125-D6902468-3F22-4EBA-9472-D8109239659D @default.
- Q91189125 P2093 Q91189125-F7FB7396-F556-4A5C-88C0-5BAF780019C8 @default.
- Q91189125 P304 Q91189125-0A3A974C-9EBA-44D3-B26E-E10BEACDD88A @default.
- Q91189125 P31 Q91189125-A18BBFA3-3F83-4A42-980D-9E1BC71CFDC7 @default.
- Q91189125 P356 Q91189125-D6531A17-888E-4E08-9CA6-892E76BAB5E9 @default.
- Q91189125 P433 Q91189125-90A4FAFB-F552-4B55-9733-DA68362638C9 @default.
- Q91189125 P478 Q91189125-6958DCC4-CB6A-4113-9F59-7C28B902936C @default.
- Q91189125 P577 Q91189125-69048B44-C061-421E-A024-0757FA9397FD @default.
- Q91189125 P698 Q91189125-AB00BC87-2F8F-4A37-A939-E5AFDA79CB94 @default.
- Q91189125 P921 Q91189125-9A59AB10-29A3-4DB3-B1A9-6FA10ADC204F @default.
- Q91189125 P932 Q91189125-404B9D43-1D24-4A3D-B9AE-158013870EE1 @default.
- Q91189125 P356 OL.2018.9766 @default.
- Q91189125 P698 30675234 @default.
- Q91189125 P1433 Q20640514 @default.
- Q91189125 P1476 "The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study" @default.
- Q91189125 P2093 "Edina Tolnay" @default.
- Q91189125 P2093 "Edit Csada" @default.
- Q91189125 P2093 "Erzsébet Juhász" @default.
- Q91189125 P2093 "György Losonczy" @default.
- Q91189125 P2093 "László Helf" @default.
- Q91189125 P2093 "Péter Dombi" @default.
- Q91189125 P2093 "Veronika Sárosi" @default.
- Q91189125 P2093 "Zsuzsanna Sztancsik" @default.
- Q91189125 P2093 "Zsuzsanna Vennes" @default.
- Q91189125 P2093 "Áron Kristóf Ghimessy" @default.
- Q91189125 P304 "1750-1760" @default.
- Q91189125 P31 Q13442814 @default.
- Q91189125 P356 "10.3892/OL.2018.9766" @default.
- Q91189125 P433 "2" @default.
- Q91189125 P478 "17" @default.
- Q91189125 P577 "2018-11-27T00:00:00Z" @default.
- Q91189125 P698 "30675234" @default.
- Q91189125 P921 Q413299 @default.
- Q91189125 P932 "6341671" @default.